Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Natus Medical has completed a public offering of 4.6 million shares of its common stock at a price of $19.50 per share, including 600,000 shares sold as a result of the underwriters' exercise of their over-allotment option in full.
Subscribe to our email newsletter
Natus will receive net proceeds from the offering, including the sale of the over-allotment shares, of approximately $84.3 million before expenses. At the completion of the offering Natus had approximately 27,566,000 shares issued and outstanding.
Cowen and Company and UBS Investment Bank acted as joint bookrunning managers for the offering and Natixis Bleichroeder, Needham & Company, Raymond James & Associates, and Roth Capital Partners acted as co-managers.